These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30349265)

  • 41. Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder.
    Hunter AM; Nghiem TX; Cook IA; Krantz DE; Minzenberg MJ; Leuchter AF
    Clin EEG Neurosci; 2018 Sep; 49(5):306-315. PubMed ID: 29224411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study.
    Kaster TS; Downar J; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Blumberger DM
    Am J Psychiatry; 2019 May; 176(5):367-375. PubMed ID: 30764649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control.
    Corlier J; Burnette E; Wilson AC; Lou JJ; Landeros A; Minzenberg MJ; Leuchter AF
    J Affect Disord; 2020 Mar; 265():272-277. PubMed ID: 32090751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Repetitive transcranial magnetic stimulation in major depression: response factor].
    Dumas R; Padovani R; Richieri R; Lançon C
    Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of MR‑less MNI based neuronavigation for 10 Hz rTMS depression therapy: electrophysiological and clinical implications.
    Valiulis V; Gerulskis G; Dapšys K; Valavičiūtė K; Šiurkutė A; Mačiulis V
    Acta Neurobiol Exp (Wars); 2018; 78(3):271-280. PubMed ID: 30295684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The role of repetitive transcranial magnetic stimulation in the treatment of mental disorders, especially in treatment-resistant major depressive disorder].
    Pilisi R; Tényi T; Büki A; Kovács N; Zemplényi A; Sebestyén G; Osváth P; Fekete S; Vörös V
    Orv Hetil; 2020 Jan; 161(1):3-10. PubMed ID: 31884813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurocognitive effects of repetitive transcranial magnetic stimulation in adolescents with major depressive disorder.
    Wall CA; Croarkin PE; McClintock SM; Murphy LL; Bandel LA; Sim LA; Sampson SM
    Front Psychiatry; 2013; 4():165. PubMed ID: 24376426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel method for identification of individualized resonant frequencies for treatment of Major Depressive Disorder (MDD) using repetitive Transcranial Magnetic Stimulation (rTMS): A proof-of-concept study.
    Leuchter AF; Wilson AC; Vince-Cruz N; Corlier J
    Brain Stimul; 2021; 14(5):1373-1383. PubMed ID: 34425244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of motor cortex excitability predicts antidepressant response to prefrontal cortex repetitive transcranial magnetic stimulation.
    Oliveira-Maia AJ; Press D; Pascual-Leone A
    Brain Stimul; 2017; 10(4):787-794. PubMed ID: 28438543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ventrolateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of depersonalization disorder: A consecutive case series.
    Jay EL; Nestler S; Sierra M; McClelland J; Kekic M; David AS
    Psychiatry Res; 2016 Jun; 240():118-122. PubMed ID: 27104926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repetitive Transcranial Magnetic Stimulation in Youth With Treatment Resistant Major Depression.
    MacMaster FP; Croarkin PE; Wilkes TC; McLellan Q; Langevin LM; Jaworska N; Swansburg RM; Jasaui Y; Zewdie E; Ciechanski P; Kirton A
    Front Psychiatry; 2019; 10():170. PubMed ID: 30984044
    [No Abstract]   [Full Text] [Related]  

  • 52. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation.
    Holtzheimer PE; Russo J; Claypoole KH; Roy-Byrne P; Avery DH
    Depress Anxiety; 2004; 19(1):24-30. PubMed ID: 14978782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy.
    Dubin MJ; Mao X; Banerjee S; Goodman Z; Lapidus KA; Kang G; Liston C; Shungu DC
    J Psychiatry Neurosci; 2016 Apr; 41(3):E37-45. PubMed ID: 26900793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents.
    Croarkin PE; Nakonezny PA; Wall CA; Murphy LL; Sampson SM; Frye MA; Port JD
    Psychiatry Res Neuroimaging; 2016 Jan; 247():25-33. PubMed ID: 26651598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial.
    Borckardt JJ; Nahas ZH; Teal J; Lisanby SH; McDonald WM; Avery D; Durkalski V; Pavlicova M; Long JM; Sackeim HA; George MS
    Brain Stimul; 2013 Nov; 6(6):925-8. PubMed ID: 23769413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression.
    Mantovani A; Aly M; Dagan Y; Allart A; Lisanby SH
    J Affect Disord; 2013 Jan; 144(1-2):153-9. PubMed ID: 22858212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image-guided neuronavigation.
    Rusjan PM; Barr MS; Farzan F; Arenovich T; Maller JJ; Fitzgerald PB; Daskalakis ZJ
    Hum Brain Mapp; 2010 Nov; 31(11):1643-52. PubMed ID: 20162598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of coil placement approaches targeting dorsolateral prefrontal cortex in depressed adolescents receiving repetitive transcranial magnetic stimulation: an electric field modeling study.
    Deng ZD; Robins PL; Dannhauer M; Haugen LM; Port JD; Croarkin PE
    medRxiv; 2023 Feb; ():. PubMed ID: 36798297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive effects of 1- and 20-hertz repetitive transcranial magnetic stimulation in depression: preliminary report.
    Little JT; Kimbrell TA; Wassermann EM; Grafman J; Figueras S; Dunn RT; Danielson A; Repella J; Huggins T; George MS; Post RM
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):119-24. PubMed ID: 10780630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repetitive transcranial magnetic stimulation reduces cigarette consumption in schizophrenia patients.
    Prikryl R; Ustohal L; Kucerova HP; Kasparek T; Jarkovsky J; Hublova V; Vrzalova M; Ceskova E
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():30-5. PubMed ID: 24211840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.